Common Contracts
4 similar Subscription Agreement contracts by Exscientia LTD, Immunocore Holdings PLC, Immunocore LTD
SUBSCRIPTION AGREEMENTSubscription Agreement • September 27th, 2021 • Exscientia LTD • Biological products, (no disgnostic substances)
SUBSCRIPTION AGREEMENTSubscription Agreement • September 10th, 2021 • Exscientia LTD • Biological products, (no disgnostic substances)
This Subscription Agreement (this “Agreement”) is made and entered into as of 1 September 2021 (the “Effective Date”), by and between Exscientia LIMITED (registered number 13483814), a private limited company incorporated in England and Wales whose registered office is The Schrodinger Building, Oxford Science Park, Oxford OX4 4GE, United Kingdom, which will be re-registered as a public limited company named Exscientia plc prior to the IPO (as defined below) (the “Company”) and Bill & Melinda Gates Foundation, a Washington charitable trust that is a tax-exempt private foundation organized and existing under the laws of Washington and having its principal place of business at 500 Fifth Avenue North, Seattle, Washington 98109, United States (the “Subscriber”).
SUBSCRIPTION AGREEMENTSubscription Agreement • February 3rd, 2021 • Immunocore Holdings PLC • Biological products, (no disgnostic substances)
This Subscription Agreement (this “Agreement”) is made and entered into as of February 3, 2021 (the “Effective Date”), by and between Immunocore Holdings Plc (registered number 13119746), a public limited company incorporated in England and Wales whose registered office is 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom OX14 4RY (the “Company”) and Bill & Melinda Gates Foundation, a Washington charitable trust that is a tax-exempt private foundation organized and existing under the laws of Washington and having its principal place of business at 500 Fifth Avenue North, Seattle, Washington 98109, United States (“Subscriber”).
FORM OF SUBSCRIPTION AGREEMENTSubscription Agreement • February 1st, 2021 • Immunocore LTD • Biological products, (no disgnostic substances)
This Subscription Agreement (this “Agreement”) is made and entered into as of February , 2021 (the “Effective Date”), by and between Immunocore Holdings Limited (registered number 13119746), a private limited company incorporated in England and Wales whose registered office is 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom OX14 4RY and which is in the process of being re-registered as a public limited company under the name Immunocore Holdings plc (the “Company”) and Bill & Melinda Gates Foundation, a Washington charitable trust that is a tax-exempt private foundation organized and existing under the laws of Washington and having its principal place of business at 500 Fifth Avenue North, Seattle, Washington 98109, United States (“Subscriber”).
